Trending
January 23, 2025 The Fresh Market Appoints Brian Johnson As CEOJanuary 23, 2025 Wali Bacdayan Joins Braemont Capital as a PartnerJanuary 23, 2025 Insilico Medicine Announces First Patient Dosed in Phase I Clinical Trial of ISM6331, the Novel Inhibitor for the Treatment of Mesothelioma and other Solid TumorsJanuary 23, 2025 Form Technologies Acquired By Ares Management For $304 MillionJanuary 23, 2025 Sword Health Acquires Surgery Hero
Featured
January 23, 2025
The Fresh Market Appoints Brian Johnson As CEO
GREENSBORO, N.C.--(BUSINESS WIRE)--The Fresh Market, Inc. today announced that its Board of Directors has appointed... Read more »
January 23, 2025
Wali Bacdayan Joins Braemont Capital as a Partner
DALLAS, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Braemont Capital, a relationship-driven investment firm that partners with... Read more »
January 23, 2025
Insilico Medicine Announces First Patient Dosed in Phase I Clinical Trial of ISM6331, the Novel Inhibitor for the Treatment of Mesothelioma and other Solid Tumors
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today... Read more »
